List of Tables
Table 1. Immune Drugs Market Trends
Table 2. Immune Drugs Market Drivers & Opportunity
Table 3. Immune Drugs Market Challenges
Table 4. Immune Drugs Market Restraints
Table 5. Global Immune Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Immune Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Immune Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Immune Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Immune Drugs Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Immune Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Immune Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Immune Drugs
Table 13. Global Immune Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Immune Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Immune Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Immune Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Immune Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Immune Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Immune Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Immune Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Immune Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Immune Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Immune Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Immune Drugs Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Immune Drugs Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Immune Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Immune Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Immune Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Immune Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Immune Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Immune Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Immune Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Immune Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Immune Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Immune Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Immune Drugs Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Immune Drugs Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Immune Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Immune Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Immune Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Immune Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Immune Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Immune Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Immune Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Immune Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Immune Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Immune Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Immune Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Immune Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Immune Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Immune Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Immune Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Immune Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Immune Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Antares Pharma, Inc. Company Information
Table 58. Antares Pharma, Inc. Introduction and Business Overview
Table 59. Antares Pharma, Inc. Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Antares Pharma, Inc. Immune Drugs Product Offerings
Table 61. Antares Pharma, Inc. Recent Development
Table 62. UCB Company Information
Table 63. UCB Introduction and Business Overview
Table 64. UCB Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. UCB Immune Drugs Product Offerings
Table 66. UCB Recent Development
Table 67. Incyte Company Information
Table 68. Incyte Introduction and Business Overview
Table 69. Incyte Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Incyte Immune Drugs Product Offerings
Table 71. Incyte Recent Development
Table 72. GSK Company Information
Table 73. GSK Introduction and Business Overview
Table 74. GSK Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. GSK Immune Drugs Product Offerings
Table 76. GSK Recent Development
Table 77. Takeda Company Information
Table 78. Takeda Introduction and Business Overview
Table 79. Takeda Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Takeda Immune Drugs Product Offerings
Table 81. Takeda Recent Development
Table 82. 3S Bio Company Information
Table 83. 3S Bio Introduction and Business Overview
Table 84. 3S Bio Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. 3S Bio Immune Drugs Product Offerings
Table 86. 3S Bio Recent Development
Table 87. Horizon Therapeutics Company Information
Table 88. Horizon Therapeutics Introduction and Business Overview
Table 89. Horizon Therapeutics Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Horizon Therapeutics Immune Drugs Product Offerings
Table 91. Horizon Therapeutics Recent Development
Table 92. Bristol-Myers Squibb (BMS Company Information
Table 93. Bristol-Myers Squibb (BMS Introduction and Business Overview
Table 94. Bristol-Myers Squibb (BMS Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Bristol-Myers Squibb (BMS Immune Drugs Product Offerings
Table 96. Bristol-Myers Squibb (BMS Recent Development
Table 97. Astellas Company Information
Table 98. Astellas Introduction and Business Overview
Table 99. Astellas Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Astellas Immune Drugs Product Offerings
Table 101. Astellas Recent Development
Table 102. Eli Lilly Company Information
Table 103. Eli Lilly Introduction and Business Overview
Table 104. Eli Lilly Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Eli Lilly Immune Drugs Product Offerings
Table 106. Eli Lilly Recent Development
Table 107. Mitsubishi Tanabe Pharma Company Information
Table 108. Mitsubishi Tanabe Pharma Introduction and Business Overview
Table 109. Mitsubishi Tanabe Pharma Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Mitsubishi Tanabe Pharma Immune Drugs Product Offerings
Table 111. Mitsubishi Tanabe Pharma Recent Development
Table 112. Biogen Company Information
Table 113. Biogen Introduction and Business Overview
Table 114. Biogen Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Biogen Immune Drugs Product Offerings
Table 116. Biogen Recent Development
Table 117. Pfizer Company Information
Table 118. Pfizer Introduction and Business Overview
Table 119. Pfizer Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Pfizer Immune Drugs Product Offerings
Table 121. Pfizer Recent Development
Table 122. Sanofi Company Information
Table 123. Sanofi Introduction and Business Overview
Table 124. Sanofi Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Sanofi Immune Drugs Product Offerings
Table 126. Sanofi Recent Development
Table 127. Roche Company Information
Table 128. Roche Introduction and Business Overview
Table 129. Roche Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Roche Immune Drugs Product Offerings
Table 131. Roche Recent Development
Table 132. Novartis Company Information
Table 133. Novartis Introduction and Business Overview
Table 134. Novartis Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Novartis Immune Drugs Product Offerings
Table 136. Novartis Recent Development
Table 137. Johnson & Johnson (J&J) Company Information
Table 138. Johnson & Johnson (J&J) Introduction and Business Overview
Table 139. Johnson & Johnson (J&J) Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Johnson & Johnson (J&J) Immune Drugs Product Offerings
Table 141. Johnson & Johnson (J&J) Recent Development
Table 142. Amgen Company Information
Table 143. Amgen Introduction and Business Overview
Table 144. Amgen Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Amgen Immune Drugs Product Offerings
Table 146. Amgen Recent Development
Table 147. Abbvi Company Information
Table 148. Abbvi Introduction and Business Overview
Table 149. Abbvi Immune Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. Abbvi Immune Drugs Product Offerings
Table 151. Abbvi Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Immune Drugs Downstream Customers
Table 155. Immune Drugs Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Immune Drugs Product Picture
Figure 2. Global Immune Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Immune Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Immune Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Immune Drugs Sales Price (2019-2030) & (US$/Unit)
Figure 6. Immune Drugs Report Years Considered
Figure 7. Global Immune Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Immune Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Drugs Revenue in 2023
Figure 10. Immune Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Immune Boosting Drugs Picture
Figure 12. Immunosuppressant Drugs Picture
Figure 13. Global Immune Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Immune Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Immune Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Immune Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Immune Drugs Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Surgery Center
Figure 21. Product Picture of Others
Figure 22. Global Immune Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Immune Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Immune Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Immune Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Immune Drugs Price by Application (2019-2030) & (US$/Unit)
Figure 27. North America Immune Drugs Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Immune Drugs Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Immune Drugs Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Immune Drugs Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Immune Drugs Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Immune Drugs Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Immune Drugs Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Immune Drugs Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Immune Drugs Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Immune Drugs Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Immune Drugs Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Immune Drugs Sales Volume (%), (2019-2030)
Figure 39. United States Immune Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Immune Drugs Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Immune Drugs Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Immune Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Immune Drugs Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Immune Drugs Sales Value by Application (%), 2023 VS 2030
Figure 45. China Immune Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Immune Drugs Sales Value by Type (%), 2023 VS 2030
Figure 47. China Immune Drugs Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Immune Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Immune Drugs Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Immune Drugs Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Immune Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Immune Drugs Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Immune Drugs Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Immune Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Immune Drugs Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Immune Drugs Sales Value by Application (%), 2023 VS 2030
Figure 57. India Immune Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Immune Drugs Sales Value by Type (%), 2023 VS 2030
Figure 59. India Immune Drugs Sales Value by Application (%), 2023 VS 2030
Figure 60. Immune Drugs Industrial Chain
Figure 61. Immune Drugs Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
